GPRE vs BIOX

For growth investors, Green Plains Inc.

(GPRE) is the stronger pick with -14. 9% revenue growth year-over-year, versus -28. 3% for Bioceres Crop Solutions Corp. (BIOX). Analysts rate Green Plains Inc. (GPRE) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Green Plains Inc.

(GPRE) delivered a total return of -47. 0%, compared to -96. 8% for Bioceres Crop Solutions Corp. (BIOX). Over 10 years, the gap is even starker: GPRE returned +21. 3% versus BIOX's -95. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Green Plains Inc.

(GPRE) is the lower-risk stock at 1. 22β versus Bioceres Crop Solutions Corp. 's 1. 94β — meaning BIOX is approximately 59% more volatile than GPRE relative to the S&P 500. On balance sheet safety, Green Plains Inc. (GPRE) carries a lower debt/equity ratio of 66% versus 94% for Bioceres Crop Solutions Corp. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Green Plains Inc.

(GPRE) is pulling ahead at -14. 9% versus -28. 3% for Bioceres Crop Solutions Corp. (BIOX). On earnings-per-share growth, the picture is similar: Green Plains Inc. grew EPS -39. 5% year-over-year, compared to -1704. 7% for Bioceres Crop Solutions Corp.. Over a 3-year CAGR, BIOX leads at 0. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Green Plains Inc.

(GPRE) is the more profitable company, earning -5. 8% net margin versus -15. 5% for Bioceres Crop Solutions Corp. — meaning it keeps -5. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BIOX leads at -1. 1% versus -4. 0% for GPRE. At the gross margin level — before operating expenses — BIOX leads at 39. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Green Plains Inc.

(GPRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 22)). Bioceres Crop Solutions Corp. (BIOX) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GPRE: +21. 3%, BIOX: -95. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.